{
  "name": "Oncology (Medical Oncology)",
  "icon": "üéóÔ∏è",
  "compensation": {
    "median": "$539,790",
    "range": "$360,250 - $703,550",
    "percentile25": "$360,250",
    "percentile50": "$539,790",
    "percentile75": "$703,550",
    "workRVUs": "5,307 (median)",
    "compensationPerRVU": "$95.80 (median)"
  },
  "painPoints": [
    {
      "category": "Access, Infusion & Capacity",
      "points": [
        "Infusion chair shortages and nursing gaps constrain treatment starts",
        "Delayed imaging and pathology turnaround slowing staging and restaging decisions",
        "Backlogs for new consults and second opinions, impacting patient satisfaction",
        "Limited clinical pharmacy and financial navigator support for complex regimens"
      ]
    },
    {
      "category": "Authorization & Financial Toxicity",
      "points": [
        "Time‚Äëconsuming prior auths for novel agents and supportive meds",
        "Step‚Äëtherapy and formulary switches disrupting evidence‚Äëbased plans",
        "High out‚Äëof‚Äëpocket costs leading to abandonment and care delays",
        "Inadequate assistance programs coordination for patients"
      ]
    },
    {
      "category": "Care Coordination & Trials",
      "points": [
        "Fragmented coordination across surgery, rad onc, and subspecialty clinics",
        "Limited access to clinical trials or slow startup timelines",
        "Tumor board preparation and follow‚Äëup adding non‚Äëbillable workload",
        "EMR inbox/calls spillover after hours"
      ]
    },
    {
      "category": "Compensation & Burnout",
      "points": [
        "RVU plans not aligned with cognitive time for complex cases and counseling",
        "Unclear credit for infusion oversight, tumor boards, and care management",
        "Emotional strain of end‚Äëof‚Äëlife care and frequent difficult conversations",
        "Pressure to expand panel size without operational investment"
      ]
    }
  ],
  "motivations": [
    "Integrated infusion center with adequate chairs and oncology‚Äëtrained nursing",
    "Clinical pharmacist and financial navigator support for regimens and copays",
    "Predictable templates with protected time for tumor board and care coordination",
    "Transparent compensation recognizing infusion oversight and complex counseling",
    "Access to clinical trials and translational programs",
    "EHR optimization, scribe support, and standardized auth workflows",
    "Opportunities for leadership (Medical Director, Disease‚Äësite Lead)",
    "Tele‚Äëoncology options for survivorship and stable follow‚Äëups",
    "Geography and school considerations for family"
  ],
  "keyQuestions": {
    "opening": [
      "Tell me about your current disease‚Äësite mix and infusion involvement.",
      "What‚Äôs motivating you to explore new opportunities right now?",
      "What would make your next role a clear upgrade?"
    ],
    "painDiscovery": [
      "Where do you see the biggest bottlenecks‚Äîinfusion capacity, imaging, or authorizations?",
      "How much time are you spending weekly on tumor boards and complex counseling?",
      "What resources would meaningfully reduce after‚Äëhours inbox work?"
    ],
    "clinical": [
      "Preferred disease‚Äësite focus and desired clinic/infusion balance?",
      "Experience with clinical trials‚Äîaccrual, PI roles, or startup processes?",
      "Comfort with oral oncolytics monitoring and toxicity management workflows?",
      "Desired support: oncology pharmacy, social work, nutrition, palliative care?"
    ],
    "motivation": [
      "When you envision your ideal oncology practice, what stands out‚Äîresources, schedule, or leadership?",
      "Rank your top three priorities: infusion capacity, compensation transparency, trials access, location, schedule."
    ],
    "compensation": [
      "Walk me through your current plan‚Äîbase, RVU, infusion oversight credit, and bonuses.",
      "What compensation structure would fairly reflect your case complexity and coordination time?"
    ]
  },
  "commonChallenges": [
    {
      "challenge": "Infusion capacity limits timely treatment starts.",
      "response": "How many chairs and what nursing ratios would meet your target patient flow?"
    },
    {
      "challenge": "Authorizations and costs derail optimal regimens.",
      "response": "Would dedicated auth teams and financial navigators change your weekly workload meaningfully?"
    },
    {
      "challenge": "RVU plan doesn‚Äôt reflect cognitive work.",
      "response": "What mix of base + RVU + care‚Äëcoordination credit would feel equitable for you?"
    },
    {
      "challenge": "Trials access is limited.",
      "response": "What trial portfolio (phase, disease sites) and startup timelines would you consider viable?"
    }
  ],
  "challengingOpportunities": [
    "If infusion access is the bottleneck, would added chairs and extended hours address your top concern?",
    "If cognitive work isn‚Äôt recognized, would explicit credit for tumor board/coordination make a new plan attractive?",
    "If trials drive your motivation, would a defined PI role with startup support align with your goals?"
  ]
}